Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation
- PMID: 34830342
- PMCID: PMC8617904
- DOI: 10.3390/ijms222212461
Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation
Abstract
Fibrogenic and inflammatory processes in the prostate are linked to the development of lower urinary tract symptoms (LUTS) in men. Our previous studies identified that osteopontin (OPN), a pro-fibrotic cytokine, is abundant in the prostate of men with LUTS, and its secretion is stimulated by inflammatory cytokines potentially to drive fibrosis. This study investigates whether the lack of OPN ameliorates inflammation and fibrosis in the mouse prostate. We instilled uropathogenic E. coli (UTI89) or saline (control) transurethrally to C57BL/6J (WT) or Spp1tm1Blh/J (OPN-KO) mice and collected the prostates one or 8 weeks later. We found that OPN mRNA and protein expression were significantly induced by E. coli-instillation in the dorsal prostate (DP) after one week in WT mice. Deficiency in OPN expression led to decreased inflammation and fibrosis and the prevention of urinary dysfunction after 8 weeks. RNAseq analysis identified that E. coli-instilled WT mice expressed increased levels of inflammatory and fibrotic marker RNAs compared to OPN-KO mice including Col3a1, Dpt, Lum and Mmp3 which were confirmed by RNAscope. Our results indicate that OPN is induced by inflammation and prolongs the inflammatory state; genetic blockade of OPN accelerates recovery after inflammation, including a resolution of prostate fibrosis.
Keywords: benign prostatic hyperplasia; chronic inflammation; extracellular matrix; lower urinary tract symptoms; prostatic fibrosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.Prostate. 2020 Jul;80(10):731-741. doi: 10.1002/pros.23986. Epub 2020 May 1. Prostate. 2020. PMID: 32356572 Free PMC article.
-
A uropathogenic E. coli UTI89 model of prostatic inflammation and collagen accumulation for use in studying aberrant collagen production in the prostate.Am J Physiol Renal Physiol. 2021 Jan 1;320(1):F31-F46. doi: 10.1152/ajprenal.00431.2020. Epub 2020 Nov 2. Am J Physiol Renal Physiol. 2021. PMID: 33135480 Free PMC article.
-
Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.Cardiovasc Res. 2017 May 1;113(6):633-643. doi: 10.1093/cvr/cvx016. Cardiovasc Res. 2017. PMID: 28453726 Free PMC article.
-
The bacteria and the host: a story of purinergic signaling in urinary tract infections.Am J Physiol Cell Physiol. 2021 Jul 1;321(1):C134-C146. doi: 10.1152/ajpcell.00054.2021. Epub 2021 May 12. Am J Physiol Cell Physiol. 2021. PMID: 33979212 Review.
-
Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis.Cells. 2019 Dec 3;8(12):1558. doi: 10.3390/cells8121558. Cells. 2019. PMID: 31816901 Free PMC article. Review.
Cited by
-
Irf7 aggravates prostatitis by promoting Hif-1α-mediated glycolysis to facilitate M1 polarization.Cell Mol Life Sci. 2025 Feb 22;82(1):90. doi: 10.1007/s00018-025-05608-w. Cell Mol Life Sci. 2025. PMID: 39985573 Free PMC article.
-
Steroid hormone imbalance drives macrophage infiltration and Spp1/osteopontin+ foam cell differentiation in the prostate.J Pathol. 2023 Jun;260(2):177-189. doi: 10.1002/path.6074. Epub 2023 Apr 4. J Pathol. 2023. PMID: 36825524 Free PMC article.
-
Systems level identification of a matrisome-associated macrophage polarisation state in multi-organ fibrosis.Elife. 2023 Sep 14;12:e85530. doi: 10.7554/eLife.85530. Elife. 2023. PMID: 37706477 Free PMC article.
-
Alterations in the balance of sex hormones may affect rat prostatic inflammation and fibrosis, and osteopontin might be involved in this process.Int Urol Nephrol. 2023 Sep;55(9):2355-2365. doi: 10.1007/s11255-023-03544-x. Epub 2023 Mar 9. Int Urol Nephrol. 2023. PMID: 36890408
-
Exploring TGF-β signaling in benign prostatic hyperplasia: from cellular senescence to fibrosis and therapeutic implications.Biogerontology. 2025 Mar 30;26(2):79. doi: 10.1007/s10522-025-10226-x. Biogerontology. 2025. PMID: 40159577 Review.
References
-
- Vuichoud C., Loughlin K.R. Benign prostatic hyperplasia: Epidemiology, economics and evaluation. Can. J. Urol. 2015;22:1–6. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous